Similar Search Results

Is it justifiable that governments promote technological progress? : lecture on the occasion of the 40th anniversary of the twinning of Bristol and Hannover

Henke, Klaus-Dirk - 1987

Persistent link: https://www.econbiz.de/10000732302

Reform of the statutory medical insurance system in the Federal Republic of Germany between utopia and pragmatism : cost cutting as a structural reform?

Cassel, Dieter; Henke, Klaus-Dirk - 1988

Persistent link: https://www.econbiz.de/10000759533

The social health economy : s regulatory framework for a healthcare system to meet the challenges of the future

Henke, Klaus-Dirk; Lohmann, Heinz; Straub, Christoph; … - 2009

Persistent link: https://www.econbiz.de/10003918285

Access and choice: competition under the roof of solidarity in German health care : an analysis of health policy reforms since 2004

Lisac, Melanie; Reimers, Lutz; Henke, Klaus-Dirk; … - In: Health economics, policy and law 5 (2010) 1, pp. 31-52

Persistent link: https://www.econbiz.de/10003970979

Finanzierung im Gesundheitswesen

Henke, Klaus-Dirk (ed.); Eimeren, Wilhelm van (contributor); … - 1986

Persistent link: https://www.econbiz.de/10008731557

Health as a driving economic force

Henke, Klaus-Dirk; Martin, Karl - 2008

Persistent link: https://www.econbiz.de/10003682512

Berlin's healthcare market as a driving economic force : a regional case study

Henke, Klaus-Dirk; Georgi, Anja - In: Health as a driving economic force. 2008

Persistent link: https://www.econbiz.de/10003685180

Towards sustainable health care systems : strategies in health insurance schemes in France, Germany, Japan and the Netherlands ; a comparative study

Henke, Klaus-Dirk; Schreyögg, Jonas - 2004

compares the health care systems of France, Germany, Japan and the Netherlands. Due to the complexity of the different …

Persistent link: https://www.econbiz.de/10009492624

Managing pharmaceutical regulation in Germany : overview and economic assessment

Schreyögg, Jonas; Henke, Klaus-Dirk; Busse, Reinhard - 2004

Rising costs in pharmaceutical expenditure have become a major concern for policy makers in Germany over the last years …. Therefore the pharmaceutical market in Germany has been increasingly targeted by different kinds of regulations, focussing both …

Persistent link: https://www.econbiz.de/10009492625

Auf dem Wege zu einer integrierten Versorgung : neue sozialrechtliche Rahmenbedingungen unter Berücksichtigung der Erfahrungen aus den USA und am Beispiel Berlins

Henke, Klaus-Dirk; Rich, Robert F.; Steinbach, Axel; … - 2004

Die vollzogene Gesundheitsreform eröffnet im Rahmen des Sozialgesetzbuches neue Möglichkeiten für Managed Care Lösungen. Bislang basierte das System auf Kollektivverträgen während Managed Care selektives Kontrahieren von Versicherungen mit Leistungsanbietern vorsieht. Im Ergebnis soll der...

Persistent link: https://www.econbiz.de/10009492627